Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 14 Oct 2021
Reviewer's report:
Author described point to point answer. I can understand the study precisely.
Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 14 Oct 2021
Reviewer's report:
Author described point to point answer. I can understand the study precisely.
Please review this paper.
user
Title: Larotinib in Patients with Advanced and Previously Treated Esophageal Squamous Cell
Carcinoma with Epidermal Growth Factor Receptor Overexpression or Amplification: An Open-
Label, Multicenter Phase 1b Study
Version: 2 Date: 14 Oct 2021
Reviewer's report:
Author described point to point answer. I can understand the study precisely.
assistant